aripiprazole has been researched along with oxytocin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chadman, KK; Guariglia, SR; Yoo, JH | 1 |
Yui, K | 1 |
Eisenstein, M | 1 |
Lord, C; Moyal, WN; Walkup, JT | 1 |
Kiss, A; Osacka, J | 2 |
Bajs JanoviĆ, M; Medved, S; MihaljeviĆ-Peleš, A; Štimac, Z | 1 |
3 review(s) available for aripiprazole and oxytocin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New directions in the treatment of autism spectrum disorders from animal model research.
Topics: Adolescent; Adolescent Behavior; Animals; Antipsychotic Agents; Aripiprazole; Brain; Central Nervous System Stimulants; Child; Child Behavior; Child Development Disorders, Pervasive; Child, Preschool; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Discovery; GluK2 Kainate Receptor; Glutamic Acid; Humans; Methylphenidate; Mice; Mice, Inbred C57BL; Oxytocin; Piperazines; Quinolones; Rats; Receptors, Kainic Acid; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2012 |
Quality of life in children and adolescents with autism spectrum disorders: what is known about the effects of pharmacotherapy?
Topics: Adolescent; Aripiprazole; Child; Child Development Disorders, Pervasive; Comorbidity; Humans; Oxytocin; Piperazines; Psychopharmacology; Psychotropic Drugs; Quality of Life; Quinolones | 2014 |
5 other study(ies) available for aripiprazole and oxytocin
Article | Year |
---|---|
[Useful pharmacologic treatment in impaired social interaction in autism spectrum disorders].
Topics: Administration, Inhalation; Antipsychotic Agents; Arachidonic Acid; Aripiprazole; Child Development Disorders, Pervasive; Child, Preschool; Humans; Interpersonal Relations; Oxytocin; Piperazines; Quinolones; Risperidone | 2012 |
Treatments: In the waiting room.
Topics: Adolescent; Adult; Animals; Aripiprazole; Autistic Disorder; Brain; Child; Clinical Trials as Topic; Drug Approval; Drug Repositioning; Humans; Oxytocin; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Trichuris; United States; United States Food and Drug Administration | 2012 |
Effect of amisulpride, olanzapine, quetiapine, and aripiprazole single administration on c-Fos expression in vasopressinergic and oxytocinergic neurons of the rat hypothalamic supraoptic nucleus.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Male; Neurons; Olanzapine; Oxytocin; Proto-Oncogene Proteins c-fos; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Supraoptic Nucleus; Vasopressins | 2020 |
The effect of amisulpride, olanzapine, quetiapine, and aripiprazole single administration on c-Fos expression in vasopressinergic and oxytocinergic neurons of the rat hypothalamic paraventricular nucleus.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Fluorescent Dyes; Gene Expression Regulation; Genes, fos; Male; Neurons; Olanzapine; Oxytocin; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Staining and Labeling; Vasopressins | 2021 |
Add-on Oxytocin in the Treatment of Postpartum Acute Schizophrenia: A Case Report.
Topics: Antipsychotic Agents; Aripiprazole; Female; Humans; Oxytocin; Postpartum Period; Schizophrenia; Young Adult | 2021 |